JNK: A new therapeutic target for diabetes

Current Opinion in Pharmacology

Volumn 3, Issue 4, 2003, Pages 420-425

  Bennett, Brydon L ^a   Satoh, Yoshitaka ^a   Lewis, Alan J ^a  

^a CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN BAD; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR PDX 1; TUMOR NECROSIS FACTOR ALPHA;

DIABETES MELLITUS; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; IMMUNE RESPONSE; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; HUMANS; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PANCREAS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041302157     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(03)00068-7     Document Type: Review

References (37)

1. Hibi M. Lin A. Minden A. Karin M. Identification of an oncoprotein and UV-responsive protein kinase that binds and protentiates the c-Jun activation domain Genes Dev. 7 1993 2135-2148
2. Derijard B. Hibi M. Wu I.-H. Barrett T. Su B. Deng T. Karin M. Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 76 1994 1025-1037
3. Shaulian E. Karin M. AP-1 as a regulator of cell life and death Nat. Cell Biol. 4 2002 E131-E136
4. Gupta S. Barrett T. Whitmarsh A.J. Cavanagh J. Sluss H. Derijard B. Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors EMBO J. 15 1996 2760-2770
5. Yang D. Kuan C. Whitmarsh A. Rincon M. Zheng T. Davis R. Rakic P. Flavell R. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene Nature 389 1997 865-870
6. Sabapathy K. Hu Y. Kallunki T. Schreiber M. David J. Jochum W. Wagner E. Karin M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development Curr. Biol. 9 1999 116-125
7. Dong C. Yang D.D. Tournier C. Whitmarsh A.J. Xu J. Davis R.J. Flavell R.A. JNK is required for effector T-cell function but not for T-cell activation Nature 405 2000 91-94
8. Tournier C. Hess P. Yang D.D. Xu J. Turner T.K. Nimnual A. Bar-Sagi D. Jones S.N. Flavell R.A. Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 2000 870-874
9. Chen Y.R. Meyer C.F. Tan T.H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis J. Biol. Chem. 271 1996 631-634
10. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis Bioessays 25 2003 17-24
11. Zagariya A. Mungre S. Lovis R. Birrer M. Ness S. Thimmapaya B. Pope R. Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun Mol. Cell Biol. 18 1998 2815-2824
12. Hotamisligil G.S. Spiegelman B.M. Tumor necrosis factor α: a key component of the obesity-diabetes link Diabetes 43 1994 1271-1278
13. Hotamisligil G.S. Murray D.L. Choy L.N. Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor Proc. Natl. Acad. Sci. U.S.A. 91 1994 4854-4858
14. Hotamisligil G.S. Peraldi P. Budavari A. Ellis R. White M.F. Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665-668
15. Ofei F. Hurel S. Newkirk J. Sopwith M. Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM Diabetes 45 1996 881-885
16. Hirosumi J. Tuncman G. Chang L. Gorgun C. Uysal K. Maeda K. Karin M. Hotamisligil G. A central role for JNK in obesity and insulin resistance Nature 420 2002 333-336
17. Virkamäki A. Uherek M. Kahn C. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance J. Clin. Invest 103 1999 931-943
18. Aguirre V. Uchida T. Yenush L. Davis R. White M.F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J. Biol. Chem. 275 2000 9047-9054
19. Ho F.M. Liu S.H. Liau C.S. Huang P.J. Lin S. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3 Circulation 101 2000 2618-2624
20. Nishikawa T. Edelstein D. Du X.L. Yamagishi S. Matsumura T. Kaneda Y. Yorek M.A. Beebe D. Oates P.J. Hammes H.P. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787-790
21. Kawano Y. Ryder J.W. Rincon J. Zierath J.R. Krook A. Wallberg H. Evidence against high glucose as a mediator of ERK1/2 or p38 MAPK phosphorylation in rat skeletal muscle Am. J. Physiol. Endocrinol. Metab. 281 2001 E1255-E1259
22. Zhou W. Zhang Y. Hosch M.S. Lang A. Zwacka R.M. Engelhardt J.F. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion Hepatology 33 2001 902-914
23. Baynes J.W. Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 48 1999 1-9
24. Whitmarsh A.J. Cavanagh J. Tournier C. Yasuda J. Davis R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation Science 281 1998 1671-1674
25. Donovan N. Becker E.B. Konishi Y. Bonni A. JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery J. Biol. Chem. 277 2002 40944-40949
26. Wang X. The expanding role of mitochondria in apoptosis Genes Dev. 15 2001 2922-2933
27. Uehara T. Bennett B. Brenner D. Sakata S. Satoh Y. JNK inhibitors protect from ischemia/reperfusion injury Hepatology 34 2001 348A
28. Bonny C. Oberson A. Negri S. Sauser C. Schorderet D.F. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death Diabetes 50 2001 77-82
29. Camp H.S. Tafuri S.R. Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity Endocrinology 140 1999 392-397
30. Kaneto H. Xu G. Fujii N. Kim S. Bonner W. Weir G.C. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression J. Biol. Chem. 277 2002 30010-30018
31. Bonny C. Nicod P. Waeber G. IB1, a JIP-1-related nuclear protein present in insulin-secreting cells J. Biol. Chem. 273 1998 1843-1846
32. Waeber G. Delplanque J. Bonny C. Mooser V. Steinmann M. Widmann C. Maillard A. Miklossy J. Dina C. Hani E.H. et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes Nat. Genet. 24 2000 291-295
33. Syed M.A. Barinas M. Pietropaolo S.L. Zhang Y.J. Henderson T.S. Kelley D.E. Korytkowski M.T. Donahue R.P. Tracy R.P. Trucco M. et al. Is type 2 diabetes a chronic inflammatory/autoimmune disease? Diabetes Nutr. Metab. 15 2002 68-83
34. Han Z. Boyle D.L. Chang L. Bennett B. Karin M. Yang L. Manning A.M. Firestein G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J. Clin. Invest 108 2001 73-81
35. Yang D. Whitmarsh A. Conze D. Barrett T. Davis R. Rincon M. Flavell R. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2 Immunity 9 1998 575-585
36. Morahan G. Huang D. Ymer S.I. Cancilla M.R. Stephen K. Dabadghao P. Werther G. Tait B.D. Harrison L.C. Colman P.G. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele Nat. Genet. 27 2001 218-221
37. Holz A. Brett K. Oldstone M.B. Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes J. Clin. Invest 108 2001 1749-1758